AskBiography Logo   Latest News  Follow Us on Twitter  Follow Us on Google Buzz  Became Fan - Facebook  Subscribe to RSSRSS   Bookmark and Share

Genzyme

Company nameGenzyme Corporation
Company typeFully Owned Subsidiary
IndustryBiotechnology
FoundedBoston, Massachusetts (1981)
HeadquartersCambridge, Massachusetts
Key peopleHenri A. Termeer, Chairman of the Board and C.E.O.
ProductsCerezyme
Fabrazyme
Synvisc
Renagel
More Complete Product List
RevenueUS $4.61 billion (2007 calendar)
Operating income(+)US $581 million (2007 calendar)
Net income(+)US $421 million (2007 calendar)
Employees12,000 (2010)
ParentSanofi-Aventis

     Home | Company | Genzyme



Genzyme Corporation (Nasdaq - GENZ) is a fully owned subsidiary of Sanofi-Aventis. Before its acquisition, Genzyme was an American biotechnology company based in Cambridge, Massachusetts. In 2010, Genzyme was the world’s third-largest biotechnology company, employing more than 11,000 people around the world. As a subsidiary of sanofi-aventis, Genzyme has a presence in approximately 40 countries, including 17 manufacturing facilities and 9 genetic-testing laboratories, its products are sold in 90 countries. In 2007, Genzyme generated $3.8 billion in revenues with more than 25 products in the market. In 2006 and 2007 Genzyme was named one of Fortune Magazine’s “100 Best Companies to Work for”. The company donated $83 million worth of products worldwide; in 2006, it made $11 million in cash donations. In 2005, Genzyme was awarded the National Medal of Technology, the highest level of honor awarded by the president of the United States to America’s leading innovators.

Genzyme Video

Genzyme has a shared commitment with the worldwide rare disease community: to raise the awareness of rare diseases. On May 15th 2011 the Dutch Rare Disease Day was celebrated in Amsterdam. A big surprise was planned for all participants. The Dutch Genzyme team, in close collaboration with the organizing committee, had organized an unannounced spectacular end to the meeting, a so called flash mob. Top choreographer Gerald van Windt, 45 professional dancers, 'The Voice of Holland' stars Shary-An and Wiep, and 'So You Think You Can Dance' finalist Natascha gave a spectacular performance to support the rare disease day theme: 'Rare but not alone'
4.28 min. | 5.0 user rating
Autologous Chondrocyte Implantation, also known as the Genzyme Procedure is a technique for regrowing cartilage in the knee. In this Video, Dr Jeffrey Halbrecht, a knee surgeon and Sports Medicine Specialist from San Francisco performs a cartilage resurfacing for a large cartilage defect of the knee in a young athlete.
1.60 min. | 5.0 user rating
North Quincy High senior Ivy Huang was the top scorer among more than 300 projects at this year's last weekend's state science fair. The achievement scored the Massachusetts Institute of Technology-bound student a $17500 scholarship through Genzyme, including an internship at the company next summer.
1.32 min. | 3.62 user rating
CNET news.com Sr. Writer Martin LaMonica takes a closer look at Genzyme's Green Headquarters in Cambridge, MA.
2.35 min. | 5.0 user rating
Genzyme held a grand opening of its Science Center at 49 New York Ave. in Framingham MA on Sept. 22, 2008. While officials and guests toured the environmentally friendly building, union workers protested outside. www.metrowestdailynews.com
2.95 min. | 5.0 user rating
www.weforum.org 15.10.2008 Interview with Henri Termeer, Chairman, presidend and Chief Executive Officer, Genzyme Corporation, USA. New Delhi, India 16-18 November. http
4.18 min. | 5.0 user rating
La biotecnológica Genzyme presenta Mozobil, un nuevo medicamento para Pacientes con linfoma o mieloma múltiple que requieran de trasplante autólogo de médula ósea tras el tratamiento inicial y que no pueden reunir células madre hematopoyéticas sufientes con los procedimientos convencionales.
2.25 min. | 5.0 user rating
Ireland Inc - public, private and non-profit have undertaken adjustments to ensure we remain competitive. From looking at our cost base, maximising opportunities for new business and focusing on operational efficiencies, Ireland is re-positioning itself in a positive way. This short 3 minute visits provides insights from top chief executives including: Danny McCoy IBEC Dominic Carolan Genzyme Fergus Murphy EBS Larry Murrin Dawn Meats Myles Lee CRH Padraig McManus ESB Pat Gallagher Baxter Patrick Manley Zurich Paul Donovan Eircom Paul O'Riordan Oracle
2.72 min. | 0 user rating
Genzyme SepraMesh presentation This may be a little gross as it shows guts
7.60 min. | 0 user rating
Genzyme CEO Henri Termeer talks about the importance of passion as a motivator in the biotech industry: "If you're trying to make a buck, there are easier ways." From the 2009 Convergence Forum in Newport, RI. www.convergenceforum.com
4.20 min. | 0 user rating

Latest News : Genzyme : Tweet this RSS

Want to Genzyme latest news on your twitter account???   sign in with twitter
Genzyme     sign in with twitter   ||  Company     sign in with twitter   ||  Economy     sign in with twitter
LabCorp to lay off 169 former Genzyme workers - Boston Herald Tweet this news
Boston Herald--By Herald Staff Laboratory Corp. of America reportedly plans to lay off 169 Westboro workers at a -Genzyme- unit it bought last December, transferring the work to North Carolina. -Genzyme- Genetics, which LabCorp bought from -Genzyme- last - Date : Thu, 21 Apr 2011 15:58:48 GMT+00:00
Watson challenges Genzyme, partner on Welchol - BusinessWeek Tweet this news
BusinessWeek--Daiichi Sankyo, based in Tokyo, and -Genzyme- responded by filing a lawsuit against Watson in the US District Court in Delaware. Generic drug developers like Watson want to be the first to bring cheaper drugs to the market and often start th - Date : Thu, 21 Apr 2011 11:39:43 GMT+00:00
FDA panels to review telaprevir, boceprevir next week; Genzyme Genetics to ... - FierceBiotech Tweet this news
FierceBiotech--Story > Employees at -Genzyme- Genetics are dealing with one of the unfortunate realities of mergers and acquisitions--layoffs. Lab Corp. of America ($LH), which bought -Genzyme- Genetics from -Genzyme- last year for $925 million, ga - Date : Thu, 21 Apr 2011 15:19:57 GMT+00:00
Laboratory Corp 1Q Net Falls As Costs Rise; Raises Year View - Wall Street Journal Tweet this news
Wall Street Journal--"The core business performed extremely well, and we are especially pleased with the performance of -Genzyme- Genetics; both of these will be important components of our future growth," said Chairman and Chief Executi - Date : Thu, 21 Apr 2011 11:48:47 GMT+00:00
At Genzyme, Laid Off Workers Lose Stock Bonus… but the CEO Keeps His - BNET (blog) Tweet this news
BNET (blog)--Before Sanofi (SNY) bought -Genzyme-, the latter began a program of 1000 layoffs to make itself more efficient. Any workers who lost their jobs instantly had their restricted stock units � shares that vest over time as an incentive � canceled - Date : Wed, 20 Apr 2011 19:48:49 GMT+00:00
PREVIEW-Sanofi Q1 profits seen down on generics, flu vaccines - Reuters Tweet this news
Reuters--PA), in the midst of digesting recently acquired US biotech -Genzyme-, will likely report lower first-quarter earnings next Thursday, squeezed by competition from generics. The results will look weak compared with a favourable quarter in 2010 whe - Date : Thu, 21 Apr 2011 15:02:13 GMT+00:00
Genzyme files patent suit over Synvisc - Bizjournals.com Tweet this news
Bizjournals.com---Genzyme- Corp, a subsidiary of French Drug maker Sanofi-Aventis, has filed suit against two companies and their subsidiaries alleging patent infringement related to its Synvisc osteoarthritis product. The law suit, filed in Massachusetts - Date : Thu, 14 Apr 2011 18:52:38 GMT+00:00
Layoffs Hit Westborough Lab - Worcester Business Journal Tweet this news
Worcester Business Journal--Laboratory Corp. of America, which last year bought -Genzyme- Genetics, will lay off 169 workers including staff in Westborough, according to an internal communication distributed by the company that was obtained by the Worcest - Date : Tue, 19 Apr 2011 16:08:05 GMT+00:00
Genzyme Stock Hits New 52-Week High (GENZ) - TheStreet.com (blog) Tweet this news
TheStreet.com (blog)--By TheStreet Wire 03/30/11 - 10:06 AM EDT NEW YORK (TheStreet) -- -Genzyme- Corporation (Nasdaq:GENZ) hit a new 52-week high Wednesday as it traded at $76.10 compared with its previous 52-Week high of $76.09. -Genzyme- is changing ha - Date : Wed, 30 Mar 2011 14:15:53 GMT+00:00
Sanofi-Aventis Sells $7 Billion In Bonds To Pay Part Of Genzyme Takeover - NASDAQ Tweet this news
NASDAQ--FR) said Wednesday it sold $7 billion worth of bonds maturing between 2012 and 2021 to partly finance its acquisition of US biotech firm -Genzyme- (GENZ) and related expenses. - $750 million in bonds maturing in 2014 paying 3-month Libor plus 0.31 - Date : Wed, 23 Mar 2011 07:05:19 GMT+00:00



Privacy | Sitemap | Micra Hosting | USA Yellow Pages